We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.4%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.23B
AUM Growth
+$1.45B
(+19%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
1,206
New
212
Increased
430
Reduced
347
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$62.9M |
| 2 |
AutoZone
AZO
|
+$61.2M |
| 3 |
Hershey
HSY
|
+$46.1M |
| 4 |
Intercontinental Exchange
ICE
|
+$41.2M |
| 5 |
General Motors
GM
|
+$40M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$104M |
| 2 |
Biogen
BIIB
|
+$89.3M |
| 3 |
Coca-Cola
KO
|
+$66.3M |
| 4 |
AbbVie
ABBV
|
+$59.1M |
| 5 |
American Homes 4 Rent
AMH
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.96% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Industrials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
HNI Corp
HNI
$3.17B
| $720K | 0.01% |
23,565
-9,913
| -30% | -$252K |
|
|
SYRS
727
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $719K | 0.01% |
6,742
+336
| +5% | +$30.2K |
|
|
SEAC
728
DELISTED
Seachange International Inc
SEAC
| $710K | 0.01% |
23,526
+14,312
| +155% | +$670K |
|
|
CHMA
729
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $705K | 0.01% |
131,123
+64,653
| +97% | +$356K |
|
730
LSI Industries
LYTS
$880M
| $701K | 0.01% |
108,324
+5,086
| +5% | +$29.3K |
|
|
ISEE
731
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $699K | 0.01% |
137,082
| – | – |
|
732
Carter Bankshares
CARE
$768M
| $696K | 0.01% |
86,207
+33,996
| +65% | +$273K |
|
733
American Coastal Insurance
ACIC
$526M
| $690K | 0.01% |
88,195
+28,181
| +47% | +$229K |
|
734
American Electric Power
AEP
$72.4B
| $688K | 0.01% |
8,640
-9,021
| -51% | -$736K |
|
735
Ezcorp Inc
EZPW
$1.85B
| $688K | 0.01% |
+109,251
| New | +$589K |
|
736
Cartesian Therapeutics
RNAC
$225M
| $688K | 0.01% |
8,073
+6,886
| +580% | +$624K |
|
737
Occidental Petroleum
OXY
$53.6B
| $687K | 0.01% |
37,527
-282,652
| -88% | -$4.45M |
|
|
LGTY
738
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $682K | 0.01% |
43,291
-3,881
| -8% | -$65.3K |
|
|
DZSI
739
DELISTED
DZS Inc. Common Stock
DZSI
| $681K | 0.01% |
76,232
-37,307
| -33% | -$249K |
|
|
CSLT
740
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $677K | 0.01% |
815,104
-3,000
| -0.4% | -$2.23K |
|
741
Pacific Biosciences
PACB
$432M
| $667K | 0.01% |
+193,469
| New | +$659K |
|
742
Camden National
CAC
$979M
| $662K | 0.01% |
19,175
+7,222
| +60% | +$228K |
|
743
Intuit
INTU
$85.6B
| $653K | 0.01% |
+2,206
| New | +$605K |
|
|
DENN
744
DELISTED
Denny's
DENN
| $648K | 0.01% |
64,174
-32,535
| -34% | -$334K |
|
745
Northrim BanCorp
NRIM
$600M
| $646K | 0.01% |
+102,860
| New | +$597K |
|
|
TCRR
746
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $643K | 0.01% |
+41,873
| New | +$483K |
|
|
DMC
747
Del Monte Corp
DMC
$1.37B
| $642K | 0.01% |
26,080
-25,296
| -49% | -$663K |
|
748
Bristol-Myers Squibb
BMY
$130B
| $640K | 0.01% |
10,879
+3,750
| +53% | +$224K |
|
749
Urban Edge Properties
UE
$2.92B
| $636K | 0.01% |
+53,561
| New | +$538K |
|
|
XHR
750
Xenia Hotels & Resorts
XHR
$2.01B
| $636K | 0.01% |
+68,148
| New | +$635K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2020 Portfolio in Review
As of Q2 2020, Jacobs Levy Equity Management held 1,206 positions worth $9.23B, up 19% from $7.78B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jacobs Levy Equity Management's Q2 2020 filing shows 212 new, 430 increased, 347 reduced and 177 closed positions. Its largest new stake was Lowe's Companies: 259,943 shares worth $35.1M. The largest sale was Mastercard, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Jacobs Levy Equity Management's largest Q2 2020 buy was Lowe's Companies: 259,943 shares worth $35.1M.
- Jacobs Levy Equity Management added most to Qualcomm in Q2 2020, an estimated $62.9M increase.
- Jacobs Levy Equity Management's biggest Q2 2020 reduction was Mastercard, cutting an estimated $104M.
- Jacobs Levy Equity Management fully exited Sysco in Q2 2020, selling an estimated $36.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 19% of its $9.23B portfolio in Q2 2020.
- Jacobs Levy Equity Management opened 212 new positions and closed 177 in Q2 2020.
- Jacobs Levy Equity Management's portfolio value rose 19% quarter-over-quarter to $9.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2020, filed 17 Aug 2020.